JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:1488-1492, doi:10.1016/S0735-1097(03)00254-7
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubartelli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubartelli, P.

Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions

Six-year clinical follow-up of the GISSOC trial

Paolo Rubartelli, MD*,*, Edoardo Verna, MD{dagger}, Luigi Niccoli, MD{ddagger}, Corinna Giachero, MD*, Marco Zimarino, MD§, Guglielmo Bernardi, MD||, Corrado Vassanelli, MD, Luigi Campolo, MD#, Eugenio Martuscelli, MD** Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche (GISSOC) Investigators

* Ospedale San Martino, Genoa, Italy
{dagger} Ospedale di Circolo, Varese, Italy
{ddagger} Spedali Civili, Brescia, Italy
§ Università di Chieti, Chieti, Italy
|| Ospedale Santa Maria della Misericordia, Udine, Italy
Università del Piemonte Orientale, Novara, Italy
# Casa di Cura Privata Villa Azzurra, Rapallo, Italy
** Policlinico Umberto I, Rome, Italy



View larger version (16K):

[in a new window]
 
Figure 1 Kaplan-Meier major adverse cardiac events (MACE)-free survival of patients assigned to stent implantation (solid line) or percutaneous transluminal coronary angioplasty (PTCA) (dashed line). The number of patients at risk for each time point is shown. MACE includes cardiac death, myocardial infarction, or target lesion revascularization.

 


View larger version (14K):

[in a new window]
 
Figure 2 Kaplan-Meier target lesion revascularization (TLR)-free survival of patients assigned to stent implantation (solid line) or percutaneous transluminal coronary angioplasty (PTCA) (dashed line). The number of patients at risk for each time point is shown.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.